AMRX
Amneal Pharmaceuticals, Inc. Class A Common StockNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$3.94B
P/E Ratio
56.14
EPS
$0.22
Beta
1.32
52W High
$15.42
52W Low
$6.68
50-Day MA
$13.45
200-Day MA
$11.14
Dividend Yield
—
Profit Margin
2.39%
Forward P/E
6.30
PEG Ratio
—
About Amneal Pharmaceuticals, Inc. Class A Common Stock
Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company is headquartered in Bridgewater, New Jersey.
Fundamentals
| Revenue (TTM) | $3.02B |
| Gross Profit (TTM) | $1.13B |
| EBITDA | $644.27M |
| Operating Margin | 14.10% |
| Return on Equity | -881.00% |
| Return on Assets | 7.32% |
| Revenue/Share (TTM) | $9.63 |
| Book Value | $-0.23 |
| Price-to-Book | 105.45 |
| Price-to-Sales (TTM) | 1.30 |
| EV/Revenue | 2.116 |
| EV/EBITDA | 10.58 |
| Quarterly Earnings Growth (YoY) | 261.00% |
| Quarterly Revenue Growth (YoY) | 11.50% |
| Shares Outstanding | $319.00M |
| Float | $185.34M |
| % Insiders | 44.04% |
| % Institutions | 49.50% |
Analyst Ratings
Consensus ($16.80 target)
3
Strong Buy2
BuyData last updated: 4/7/2026